|
Sign In to gain access to subscriptions and/or personal tools.
|
Ankle—brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort
Laura M. Reich
Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA
Gerardo Heiss
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Lori L. Boland
Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA
Alan T. Hirsch
Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA, Minneapolis Heart Institute, Minneapolis, MN, USA
Kenneth Wu
Division of Hematology, University of Texas Medical School, Houston, TX, USA
Aaron R. Folsom
Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA, folsom{at}epi.umn.edu
To determine whether elevated levels of hemostatic and inflammatory markers [von Willebrand factor (vWF), fibrinogen, D-dimer, factor VII, factor VIII, PAI-1, tPA, beta-thromboglobulin (β-TG), CRP, and WBC count] are associated with increased peripheral arterial disease (PAD) prevalence, measured by low ABI, we studied 13,778 participants from the ARIC study in a cross-sectional analysis after adjustment for major cardiovascular risk factors. PAD was positively associated with fibrinogen, vWF, factor VIII, WBC count, D-dimer, β-TG, and CRP (p for trend <0.05) but not with the other markers. Adjusted odds ratios for the highest versus the lowest quartile of fibrinogen in men and women, respectively, were 3.49 (95% CI 1.68—7.26) and 2.44 (95% CI 1.58—3.77); for vWF 2.36 (95% CI 1.36—4.07) and 1.45 (95% CI 1.00—2.10); for factor VIII 2.31 (95% CI 1.36—3.94) and 1.68 (95% CI 1.14—2.48). In a smaller subset, the sex and risk factor adjusted odds ratio for the highest versus the lowest quartile of D-dimer was 2.70 (95% CI 1.56—4.65), for β-TG was 1.80 (95% CI 1.12—2.88), and for CRP was 1.57 (95% CI 0.84—2.95). Plasma levels of hemostatic and inflammatory markers are elevated in PAD, suggesting these processes are involved in the pathophysiology of PAD.
Key Words: atherosclerosis blood coagulation factors hemostasis peripheral vascular disease
References
- Newman AB, Sutton-Tyrell K., Rutan GH, Locher J., Kuller LH Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol 1991; 44: 15—20.[Web of Science][Medline]
[Order article via Infotrieve]
- Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2: 221—26.[Medline]
[Order article via Infotrieve]
- Meijer WT, Hoes AW, Rutgers D., Bots ML, Hofman A., Grobbee DE Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185—92.[Abstract/Free Full Text]
- Fowkes FG, Housley E., Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384—92.[Abstract/Free Full Text]
- Criqui MH, Fronek A., Barrett-Connor E., Klauber MR, Gabriel S., Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510—15.[Abstract/Free Full Text]
- Fowkes FGR. Epidemiology of peripheral vascular disease. Atherosclerosis 1997; 131(suppl): S29—S31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Criqui MH, Langer RD, Froneck A. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381—86.[Abstract]
- Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172—81.[Abstract/Free Full Text]
- Newman AB, Shemanski L., Manolio TA et al. Ankle—arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 538—45.[Abstract/Free Full Text]
- Assman G., Cullen P., Heinrich J., Schulte H. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Munster Heart Study (PROCAM). Prospective Cardiovascular Munster Study. Isr J Med Sci 1996; 32: 364—70.[Web of Science][Medline]
[Order article via Infotrieve]
- Thompson SG, Kienast J., Pyke SDM, Haverkate F., van de Loo JCW for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635—41.[Abstract/Free Full Text]
- Tracy RP, Arnold AM, Ettinger W., Fried L., Meilahn E., Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999; 19: 1776—83.[Abstract/Free Full Text]
- Folsom AR, Rosamond WD, Shahar E. et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999; 100: 736—42.[Abstract/Free Full Text]
- Folsom AR, Wu KK, Rosamond WD, Sharrett A., Richey A., Chambless LE Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96: 1102—108.[Abstract/Free Full Text]
- Folsom AR, Aleksic N., Park E., Salomaa V., Juneja H., Wu KK Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 611—17.[Abstract/Free Full Text]
- Meade TW, Mellows S., Brozovic M. et al. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533—37.
- Bogaty P., Poirier P., Simard S., Boyer L., Solymoss S., Dagenais GR Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 2001; 103: 3062—68.[Abstract/Free Full Text]
- Lowe GD, Fowkes FG, Dawes J., Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87: 1915—20.[Abstract/Free Full Text]
- Newman AB, Siscovick DS, Manolio TA et al. Ankle—arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993; 88: 837—45.[Abstract/Free Full Text]
- Tzoulaki I., Murray GD, Price JF et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: The Edinburgh Artery Study. Am J Epidemiol 2005; 163: 334—41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Allison MA, Criqui MH, McClelland RL et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 48: 1190—97.[Abstract/Free Full Text]
- McDermott MM, Guralnik JM, Corsi A. et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 2005; 150: 276—81.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481—85.[Abstract/Free Full Text]
- Philipp CS, Cisar LA, Kim HC, Wilson AC, Saidi P., Kostis JB Association of hemostatic factors with peripheral vascular disease. Am Heart J 1997; 134: 978—84.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Blann AD, Seigneur M., Steiner M., Boisseau MR, McCollum CN Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916—21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McDermott MM, Green D., Greenland P. et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003; 92: 194—99.[Web of Science][Medline]
[Order article via Infotrieve]
- Aboyans V., Criqui MH, Denenberg JO et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623—29.[Abstract/Free Full Text]
- McDermott MM, Ferrucci L., Liu K. et al. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2005; 53: 1688—96.[Web of Science][Medline]
[Order article via Infotrieve]
- McDermott MM, Greenland P., Green D. et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003; 107: 3191—98.[Abstract/Free Full Text]
- The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687—702.[Abstract/Free Full Text]
- Mundt KA, Chambless LE, Burnham CB, Heiss G. Measuring ankle systolic blood pressure: validation of the Dinamap 1846 SX. Angiology 1992; 43: 555—66.[Abstract/Free Full Text]
- Weatherley BD, Nelson JJ, Heiss G. et al. The association of the ankle—brachial index with incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, 1987—2001. BMC Cardiovasc Disord 2007; 7: 3.[CrossRef][Medline]
[Order article via Infotrieve]
- Aboyans V., Criqui MH, McClelland RL et al. Intrinsic contribution of gender and ethnicity to normal ankle—brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg 2007; 45: 319—27.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Papp AC, Hatzakis H., Bracey AW, Wu KK ARIC Hemostasis Study-1. Development of a blood collection and processing system suitable for multicentric studies. Thromb Haemost 1989; 61: 15—19.[Web of Science][Medline]
[Order article via Infotrieve]
- Chambless L., McMahon R., Wu K., Folsom A., Finch A., Shin YL Short-term intraindividual variability in hemostasis factors. The ARIC Study. Ann Epidemiol 1992; 2: 723—33.[Medline]
[Order article via Infotrieve]
- Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499—502.[Abstract]
- ARIC Protocol Manual 9. Hemostasis determinations. Chapel Hill, NC: National Heart Lung and Blood Institute of the National Institutes of Health Collaborative Studies Coordinating Center, University of North Carolina, 1987.
- Nguyen ND, Ghaddar H., Stinson V., Chambless LE, Wu K. ARIC Hemostasis Study-IV. Intraindividual variability and reliability of hemostasis factors. The Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost 1995; 73: 256—60.[Web of Science][Medline]
[Order article via Infotrieve]
- Folsom AR, Aleksic N., Catellier D., Juneja HS, Wu KK C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities study. Am Heart J 2002; 144: 233—38.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fowkes FGR, Lowe GDO, Housley E. et al. Cross-linked fibrin degradation products and the progression of peripheral arterial disease and risk of coronary heart disease. Lancet 1993; 342: 84—86.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Smith FB, Lee AJ, Rumley A., Fowkes FG, Lowe GD Tissue plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 1995; 115: 35—43.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mackiewicz A., Speroff T., Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991; 146: 3032—37.[Abstract]
- Hurlimann J., Thorbecke GJ, Hochwald GM The liver as the site of C-reactive protein formation. J Exp Med 1966; 123: 365—78.[Abstract]
- Ridker PM, Cushman M., Stampfer MJ, Tracy RP, Hennekens CH Plasma concentration of C-reactive protein and risk of developing peripheral arterial disease. Circulation 1998; 97: 425—28.[Abstract/Free Full Text]
- Tracy RP Inflammatory markers and coronary heart disease. Curr Opin Lipidol 1999; 10: 435—41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Vascular Medicine, Vol. 12, No. 4,
267-273 (2007)
DOI: 10.1177/1358863X07082767

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. J Khawaja and I. J Kullo
Novel markers of peripheral arterial disease
Vascular Medicine,
November 1, 2009;
14(4):
381 - 392.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Agarwal
The Association of Active and Passive Smoking With Peripheral Arterial Disease: Results From NHANES 1999-2004
Angiology,
June 1, 2009;
60(3):
335 - 345.
[Abstract]
[PDF]
|
 |
|
|
|